Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Exercise Performance
Launched by PEPSICO GLOBAL R&D · May 16, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how heart rate variability (HRV) relates to exercise training and performance. HRV is a measure of how much time varies between each heartbeat, which can give us insights into how well your body is ready for exercise and how well it's recovering. The study will use Whoop wrist-worn activity trackers, which are designed to continuously monitor heart rate and provide personalized training recommendations based on HRV. This research aims to see if using HRV data in real-world training can help improve exercise performance more effectively than following a standard training plan.
To participate, you need to be between 21 and 50 years old and currently engage in resistance training 2 to 4 times a week. Participants will need to wear the Whoop device continuously, including while sleeping, and avoid vigorous exercise and alcohol 24 hours before study visits. This study is open to both men and women, and it’s a great opportunity to learn how understanding your body's signals can enhance your workout routine. If you have any health issues or conditions that might interfere with the study, you may not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Actively participating in resistance training 2-4 times per week.
- • 2. Age 21-50 years, male and female.
- • 3. Subject is willing to refrain from vigorous exercise (light physical activity only) 24 hours prior to visit(s).
- • 4. Subject is willing to avoid alcohol consumption 24 hours prior to visit(s).
- • 5. Subject is willing to provide consent.
- • 6. Subject is able to continuously wear a wrist-worn device, including during sleep, except when submerged underwater (i.e., swimming, bathing).
- Exclusion Criteria:
- • 1. Individual has a condition the Investigator believes would interfere with his ability to provide informed consent, comply with the project/study protocol, which might confound the interpretation of the project/study results or put the person at undue risk.
- • 2. Those with a medical history that would interfere with the results of this study.
- • 3. Under the care of a physician.
- • 4. Skin sensitivities.
- • 5. Sleep disorders.
- • 6. Using prescription medications that would impact sleep.
- • 7. If female, you are not pregnant, planning to get pregnant or currently breast feeding.
- • 8. Smoker.
- • 9. Not able to wear wrist-worn device continuously.
- • 10. Lack of proficiency in English.
- • 11. Lack of proficiency or access to the internet and email address.
- • 12. Participation in another clinical trial within the past 30 days.
- • 13. Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.
About Pepsico Global R&D
PepsiCo Global R&D is a leading innovator in the food and beverage industry, dedicated to advancing the science of nutrition and product development. With a strong focus on health and wellness, the organization conducts rigorous clinical trials to explore the efficacy and safety of its products, aiming to enhance consumer experiences while promoting sustainable practices. Leveraging cutting-edge research methodologies and a multidisciplinary approach, PepsiCo Global R&D collaborates with academic institutions and healthcare professionals to drive evidence-based advancements in nutrition, ensuring that its offerings meet the evolving needs of consumers worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Frisco, Texas, United States
Patients applied
Trial Officials
Corey Ungaro, PhD
Principal Investigator
PepsiCo, Inc. Sports Science
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported